Cortisone Acetate Market is Projected to increase at a CAGR of around 3.3% during 2023 to 2031: Exclusive report by Growth Plus Reports

Newark, New Castle, USA, June 05, 2023 (GLOBE NEWSWIRE) — The market analysis of the global cortisone acetate market was conducted by Growth Plus Reports in 2022. The market is expected to hit a revenue CAGR of 3.3% by 2031.

Asthma, dermatitis, and arthritis are just a few of the inflammatory disorders that are commonly treated with cortisone acetate, a synthetic corticosteroid. The rising incidence of these disorders is driving the demand for cortisone acetate. As the population ages, age-related inflammatory conditions, including osteoarthritis and rheumatoid arthritis, are becoming increasingly prevalent. This demographic trend is a significant driver for the cortisone acetate market. 

Advertisement

Technological advancements in drug delivery systems have improved the efficacy and convenience of cortisone acetate administration. Developing novel formulations, including sustained-release implants and injectables, has boosted the demand for cortisone acetate. The market has grown as a result of greater consumer knowledge of the advantages of cortisone acetate in treating inflammatory conditions and improved access to healthcare services.

Get a Free Sample Research Report: https://www.growthplusreports.com/inquiry/request-sample/cortisone-acetate-market/9094

                           Cortisone Acetate Market Scope

Report Attribute Details
CAGR 3.3%
Base Year for Estimation 2022
Forecast Period 2023 to 2031
Historical Year 2021
Segments Covered Indication, Route of Administration, Distribution Channel, and Region
Forecast Period North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

Competitive Landscape

Following are the top market players operating in the global market for cortisone acetate includes: 

  • Hikma Pharmaceuticals USA Inc.
  • Chartwell Rx, Llc
  • Merck & Co., Inc.

Market Segmentation: 

  • Four viewpoints are used to assess the worldwide cortisone acetate market: indication, method of administration, distribution channel, and geography. 
  • North America accounted for the greatest revenue share in the worldwide market for cortisone acetate in 2022 and is anticipated to grow at a CAGR of 3.15% over the forecast period.
  • The worldwide cortisone acetate market is segmented based on indication into gastrointestinal disorders, rheumatic illnesses, dermatologic problems, ophthalmic diseases, respiratory diseases, etc.
  • Because dermatological problems are becoming more common, the dermatologic conditions segment commanded the most revenue share in the market in 2022. 
  • The worldwide market for cortisone acetate has been segmented into oral and parenteral segments based on the method of administration.
  • In terms of revenue, the parenteral category dominated the market in 2022. Cortisone acetate is supplied by non-oral routes such as injections, infusions, or implants when using the parenteral mode of administration. 
  • The worldwide market for cortisone acetate is segmented into oral and parenteral segments based on the method of administration.
  • In terms of revenue, the parenteral category dominated the market in 2022. Cortisone acetate is supplied by non-oral routes such as injections, infusions, or implants when using the parenteral mode of administration.

Request for Customization – https://www.growthplusreports.com/inquiry/customization/cortisone-acetate-market/9094

Market Restraints:

Prolonged use of cortisone acetate can lead to various side effects, such as immunosuppression, osteoporosis, weight gain, and hypertension. Concerns about these side effects can limit the adoption of cortisone acetate and restrain market growth. There are alternative treatment options available for certain inflammatory disorders, including non-steroidal anti-inflammatory drugs (NSAIDs) and biologic agents. The availability of these alternatives may impact the demand for cortisone acetate. 

Stringent regulations regarding the manufacturing, marketing, and approval of cortisone acetate can challenge market players. Compliance with regulatory requirements and obtaining necessary approvals can be time-consuming and costly.

Table of Content

  1. INTRODUCTION
    1. Market Ecosystem
    2. Timeline Under Consideration
      1. Historical Years – 2021
      2. Base Year – 2022
      3. Forecast Years – 2023 to 2031
    3. Currency Used in the Report
  2. RESEARCH METHODOLOGY 
    1. Research Approach
    2. Data Collection Methodology
    3. Data Sources
      1. Secondary Sources 
      2. Primary Sources
    4. Market Estimation Approach
      1. Bottom Up
      2. Top Down 
    5. Market Forecasting Model
    6. Limitations and Assumptions
  3. PREMIUM INSIGHTS
    1. Current Market Trends (COVID-19 Perspective)
    2. Key Players & Competitive Positioning (2022) 
    3. Regulatory Landscape
  4. MARKET DYNAMICS
    1. Drivers
    2. Restraints/Challenges
    3. Opportunities
  5. GLOBAL CORTISONE ACETATE MARKET – ANALYSIS & FORECAST, BY INDICATION
    1. Rheumatic Diseases 
    2. Dermatologic Conditions
    3. Ophthalmic Diseases 
    4. Respiratory Diseases
    5. Gastrointestinal Disorders
    6. Others
  6. GLOBAL CORTISONE ACETATE MARKET – ANALYSIS & FORECAST, BY ROUTE OF ADMINISTRATION
    1. Oral 
    2. Parenteral
  7. GLOBAL CORTISONE ACETATE MARKET – ANALYSIS & FORECAST, BY DISTRIBUTION CHANNEL
    1. Hospital Pharmacies 
    2. Retail Pharmacies 
    3. Online Pharmacies

CORTISONE ACETATE MARKET TOC

Buy this Premium Research Report: https://www.growthplusreports.com/checkout-9094

VALUE PROPOSITIONS RELATED TO THE REPORT:

  • Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
  • Comprehensive quantitative and qualitative insights at segment and sub-segment level
  • Covid 19 impact trends and perspective
  • Granular insights at global/regional/country level
  • Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
  • Blanket coverage on competitive landscape
  • Winning imperatives
  • Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market.

CUSTOMIZATION OPTIONS:

  • Distributor Landscape Assessment
  • Pricing Intelligence
  • Customer Base Assessment
  • Investment & Initiatives Analysis
  • ‘Business Profile’ of Key Players

Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction

Visit our report store at – https://www.growthplusreports.com/report-store

Browse more latest healthcare reports:

Total Reflection X-Ray Fluorescence Spectrometer Market by Type (Portable, Multi-Element), Application (Food Industry, Pharmaceutical Industry) – Global Outlook & Forecast 2023-2031

Biologic Response Modifiers Market by Type (Monoclonal Antibodies, Interleukins), Application (Autoimmune Diseases, Cancer) – Global Outlook & Forecast 2023-2031

Medical Aesthetics Market by Type (Energy-Based Devices, Non-Energy Based Devices), Application (Body Contouring and Cellulite Reduction, Hair and Tattoo Removal), End User (Hospitals, Specialty Clinics, Others) – Global Outlook & Forecast 2023-2031

Anorectal Drugs Market by Indication (Dermatological Disorders, Hemorrhoids), Drug Class (Corticosteroids, Anti-infectives), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031

Nummular Eczema Treatment Market by Drug Class (Immunomodulators, Antibiotics, Antihistamines), Route of Administration (Topical, Oral, Parenteral), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Global Outlook & Forecast 2023-2031

Unleashing the Power of Innovation in Med Tech https://growthplusmedtechroundup.com/

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020”.



Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.